| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699001 | Clinical Oncology | 2010 | 6 Pages |
Abstract
Current surveillance methods do not appear to improve cancer control in the stage III/IV head and neck squamous cell carcinoma population. However, technological advances and biomarker development may lead to surveillance technique enhancements. Also, post-treatment follow-up remains important for the evaluation of treatment results, emotional support and management of late complications. Among the clinical and pathological factors considered, only the treatment response and perineural invasion predicted survival.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
C.J. Flynn, N. Khaouam, S. Gardner, K. Higgins, D. Enepekides, J. Balogh, R. MacKenzie, S. Singh, J. Davidson, I. Poon,